Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
October 31, 2017
Aimmune Therapeutics Announces Publication in The Journal of Allergy and Clinical Immunology: In Practice of Positive AR101 Data from ARC001 Phase 2 Clinical Trial
BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the online publication of positive data from ...
October 31, 2017
LifeSci Advisors Announces 11th Board Appointment Through Board Placement Initiative
NEW YORK, Oct. 31, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, an investor relations and corporate communications firm focused on the life sciences sector, announced today the ...
October 31, 2017
ASPiRA Labs Announces OVA1 Contract with Louisiana Blue Cross Blue Shield
AUSTIN, Texas, Oct. 31, 2017 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (VRML) and exclusive distributor of OVA1 (Multivariate Index Assay, or MIA), an ovarian ...
October 30, 2017
BIOPHYTIS Has FDA Approval to Initiate SARA-INT Phase 2b Interventional Study of Sarconeos in Sarcopenia
PARIS, Oct. 30, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related ...
October 30, 2017
Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy
VANCOUVER , Oct. 30, 2017 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response ...
October 30, 2017
BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2017 Financial Results on November 9
RALEIGH, N.C., Oct. 30, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) announced that it will report its third quarter 2017 financial results and host ...
October 30, 2017
Aptose Enters into $15.5 Million Common Shares Purchase Agreement with Aspire Capital Fund, LLC
SAN DIEGO and TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
October 30, 2017
VBI Vaccines Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Upsized Registered Direct Offering for Aggregate Proceeds of $71.9 Million
CAMBRIDGE, Mass., Oct. 30, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, ...
October 30, 2017
Arena Pharmaceuticals to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 7
SAN DIEGO, Oct. 30, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), today announced that the Company will release its third quarter 2017 financial results and provide ...
October 30, 2017
Rockwell Medical Announces Two Triferic Poster Presentations at American Society of Nephrology Kidney Week 2017 Annual Meeting
WIXOM, Mich., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), announced today that two poster presentations for Triferic have been selected by the ...
October 30, 2017
Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017
WALTHAM, Mass., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
October 30, 2017
Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase 1b Study of OXi4503 in Acute Myeloid Leukemia
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan ...
October 30, 2017
Transgene to Present Additional Immunology Data from the TIME trial with TG4010 in patients with advanced lung cancer at SITC 2017
STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (TNG.PA), a biotech company that designs and develops viral-based immunotherapies, will be presenting a poster on additional immunology data generated from ...
October 30, 2017
Achaogen to Host Conference Call and Webcast of Third Quarter 2017 Financial Results on November 8, 2017
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant ...
October 27, 2017
Onxeo Provides Strategy Update and Reports 2017 Third Quarter Financial Information
PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (ONXEO.PA) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO – ISIN FR0010095596), (“Onxeo” or the “Company”), a clinical-stage biotechnology company specializing ...
October 27, 2017
CorMedix Inc. to Present Candida auris Susceptibility Data at 2nd Annual Gulf Congress of Clinical Microbiology and Infectious Diseases
BERKELEY HEIGHTS, NJ / ACCESSWIRE / October 26, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
October 27, 2017
DURECT Corporation Invites You to Join its Third Quarter 2017 Earnings Conference Call
CUPERTINO, Calif., Oct. 26, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's (DRRX) third quarter 2017 financial results press release, you are invited to listen to a conference ...
October 27, 2017
ASPiRA Labs Lands Strategic Managed Care Coverage and Medicaid Licensure for OVA1®
AUSTIN, Texas, Oct. 27, 2017 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (VRML), today announced it has entered into agreements with Joint Venture Hospital Laboratories, LLC ("JVHL"), ...
October 27, 2017
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress
SAN DIEGO--(BUSINESS WIRE) -- La Jolla Pharmaceutical Company (LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes ...
October 27, 2017
Biophytis Appoints Professor Thomas Voit to Scientific Advisory Board to Help Accelerate Pipeline Programs in Orphan Pediatric Diseases
BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company focused on innovative therapeutics to restore the muscular and visual functions in diseases with significant unmet medical needs, ...
Page 83 of 117